Search Results - "Demeusoit C"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    TG6050, an oncolytic vaccinia virus encoding interleukin-12 and anti-CTLA-4 antibody, favors tumor regression via profound immune remodeling of the tumor microenvironment.

    Authors: Azar F Deforges J Demeusoit C et al.

    Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Jul 25; Vol. 12 (7). Date of Electronic Publication: 2024 Jul 25.

    Publication Type: Journal Article

    Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

    Save to List
  2. 2

    Bridging mechanism and clinic: unlocking the full potential of oncolytic virus-based immunotherapy.

    Authors: Hua X Tang H Liang K et al.

    Source: Molecular cancer [Mol Cancer] 2026 Mar 31; Vol. 25 (1). Date of Electronic Publication: 2026 Mar 31.

    Publication Type: Journal Article; Review

    Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598 (Electronic) Linking ISSN: 14764598 NLM ISO Abbreviation: Mol Cancer Subsets: MEDLINE

    Save to List
  3. 3

    Vaccinia virus for lung cancer therapy: preclinical progress and prospects as a systemic immunotherapy platform.

    Authors: Li L Chen Z Yan Y et al.

    Source: Frontiers in immunology [Front Immunol] 2026 May 07; Vol. 17, pp. 1797922. Date of Electronic Publication: 2026 May 07 (Print Publication: 2026).

    Publication Type: Journal Article; Review

    Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

    HTML Full Text PDF Full Text
    Save to List
  4. 4

    Enhancing Oncolytic Virus Therapy with Nanomedicine: A Review of Progress, Challenges, and Future Directions in a New Frontier of Cancer Treatment.

    Authors: Qiu J Liao Y Kan D et al.

    Source: International journal of nanomedicine [Int J Nanomedicine] 2026 Apr 07; Vol. 21, pp. 587972. Date of Electronic Publication: 2026 Apr 07 (Print Publication: 2026).

    Publication Type: Journal Article; Review

    Journal Info: Publisher: DOVE Medical Press Country of Publication: New Zealand NLM ID: 101263847 Publication Model: eCollection Cited Medium: Internet ISSN: 1178-2013 (Electronic) Linking ISSN: 11769114 NLM ISO Abbreviation: Int J Nanomedicine Subsets: MEDLINE

    HTML Full Text PDF Full Text
    Save to List
  5. 5

    Research progress on recombinant NDV in cancer therapy.

    Authors: Sun J Wang J Xiao M et al.

    Source: Frontiers in immunology [Front Immunol] 2025 Dec 17; Vol. 16, pp. 1735440. Date of Electronic Publication: 2025 Dec 17 (Print Publication: 2025).

    Publication Type: Journal Article; Review

    Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

    HTML Full Text PDF Full Text
    Save to List
  6. 6

    Oncolytic virus therapy in the elderly: immune frailty, challenges, and perspectives.

    Authors: Wang JW Liu JH Liu YL et al.

    Source: Frontiers in immunology [Front Immunol] 2025 Oct 08; Vol. 16, pp. 1686659. Date of Electronic Publication: 2025 Oct 08 (Print Publication: 2025).

    Publication Type: Journal Article; Review

    Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

    HTML Full Text PDF Full Text
    Save to List
  7. 7

    Recombinant Oncolytic Viruses: Hexagonal Warriors in the Field of Solid Tumor Immunotherapy.

    Authors: Zhang C Sun Q

    Source: Current issues in molecular biology [Curr Issues Mol Biol] 2025 Oct 23; Vol. 47 (11). Date of Electronic Publication: 2025 Oct 23.

    Publication Type: Journal Article; Review

    Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 100931761 Publication Model: Electronic Cited Medium: Internet ISSN: 1467-3045 (Electronic) Linking ISSN: 14673037 NLM ISO Abbreviation: Curr Issues Mol Biol Subsets: PubMed not MEDLINE

    HTML Full Text PDF Full Text
    Save to List

Search Tools: